Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Change in Accrued Expenses (2021 - 2026)

Updated

Bristol Myers Squibb (BMY) recorded Change in Accrued Expenses of -$734 million in Q3 2026, compared with $1.7 billion a year earlier.

Analysis

Bristol Myers Squibb (BMY) Change in Accrued Expenses (2021 - 2026) Analysis & Trends

On a TTM basis, Bristol Myers Squibb's Change in Accrued Expenses came in at -$6.27 billion as of Sep 30, 2026; for FY2025, it came in at -$441 million.

  • Across earlier years, Change in Accrued Expenses came in at $1.48 billion in FY2024 (+64.2%), $904 million in FY2023 (+111.7%), $427 million in FY2022 (-50.5%) and $863 million in FY2021 (-27.4%).
  • Quarterly Change in Accrued Expenses has ranged from -$3.5 billion in Q1 2026 to $1.82 billion in Q3 2024 over the past five years.
  • Peak year-over-year performance for Change in Accrued Expenses in the last five years was growth of 141.9% in Q2 2022, against a decline of 59.1% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $360 million (Q2 2026), -$3.5 billion (Q1 2026) and -$2.4 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.41 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 983.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 756.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn -734.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -734.00 Mn
Jun 30, 2026 360.00 Mn
Mar 31, 2026 -3.50 Bn
Dec 31, 2025 -2.40 Bn
Sep 30, 2025 1.70 Bn
Jun 30, 2025 881.00 Mn
Mar 31, 2025 -627.00 Mn
Dec 31, 2024 -405.00 Mn
Sep 30, 2024 1.82 Bn
Jun 30, 2024 735.00 Mn
Mar 31, 2024 -665.00 Mn
Dec 31, 2023 -211.00 Mn
Sep 30, 2023 1.53 Bn
Jun 30, 2023 492.00 Mn
Mar 31, 2023 -910.00 Mn
Dec 31, 2022 -303.00 Mn
Sep 30, 2022 1.14 Bn
Jun 30, 2022 520.00 Mn
Mar 31, 2022 -930.00 Mn
Dec 31, 2021 -39.00 Mn
API Access

Bristol Myers Squibb Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BMY&period=max&api_key=YOUR_API_KEY